Alexza Pharmaceuticals Inc (NASDAQ:ALXA)
| 4.59 Data as of Jun 17 |  -0.05 / -1.08%Today’s Change | 2.55 Today|||52-Week Range 6.65 | -7.27% Year-to-Date |
Latest ALXA News | Press Releases
No recent news for Alexza Pharmaceuticals Inc.
Today’s Trading
| Previous close | 4.64 |
| Today’s open | 4.66 |
| Day’s range | 4.58 - 4.67 |
| Volume | 102,787 |
| Average volume (3 months) | 419,919 |
| Market cap | $80.0M |
| Dividend yield | -- |
Data as of 4:00pm ET, 06/17/2013
Growth & Valuation
| Earnings growth (last year) | +62.67% |
| Earnings growth (this year) | -22.77% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -28.09% |
| P/E ratio | NM |
| Price/Sales | 15.17 |
| Price/Book | 28.43 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SYNSynthetic Biologics ... | -0.06 | -3.31% |
| ADHDAlcobra Ltd | -0.15 | -2.11% |
| APRIApricus Biosciences ... | -0.13 | -4.66% |
| DRRXDURECT Corp | -0.02 | -2.41% |
Data as of 4:00pm ET, 06/17/2013
Financials
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | -$0.51 |
| Annual revenue (last year) | $4.1M |
| Annual profit (last year) | -$28.0M |
| Net profit margin | -687.42% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Thomas Braxton King, MBA |
Senior Vice President-Operations & Manufacturing Michael J. Simms, MBA |
Corporate headquarters Mountain View, California |
Forecasts
